Chronic, recurrent Lymphocytic Leukemia Completed Phase 2 Trials for Beta-D-Glucose (DB02379)

Also known as: Recurrent Chronic Lymphocytic Leukemia

Indication	Status	Phase
DBCOND0112002 (Chronic, recurrent Lymphocytic Leukemia)	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT01008462	Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia	Treatment	Beta-D-Glucose (DB02379) Carmustine (DB00262) Cyclophosphamide (DB00531) Cytarabine (DB00987) Etoposide (DB00773) Fludarabine (DB01073) Mechlorethamine (DB00888) Mycophenolate mofetil (DB00688) Tacrolimus (DB00864)